Trial Profile
Alimta Plus Gemcitabine as Chemotherapy for Patients With Advanced Sarcoma: A Phase II Clinical.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Aug 2020
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Pemetrexed (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 12 Feb 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 12 Mar 2009 New trial record